Adult Growth Hormone Deficiency Clinical Trials

47 clinical trials for Adult Growth Hormone Deficiency across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Safety, Pharmacokinetic (PK) Profile and Efficacy of Inpegsomatropin Injection in Adults With Growth Hormone Deficiency — RECRUITING · PHASE2
• Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD) — RECRUITING · PHASE3
• A Study to Follow Patients With Adult Growth Hormone Deficiency (AGHD) Treated With Sogroya® for Long Term Safety Information — RECRUITING
• Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT) — RECRUITING · PHASE2
• A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD) — RECRUITING · PHASE1
• A clinical study in AGHD to assess safety, tolerability and efficacy of GX-H9 — COMPLETED · PHASE2
• A Safety, Pharmacokinetic and Pharmacodynamic Study of ACP-001 (TransCon hGH) in Adults With Growth Hormone Deficiency — COMPLETED · PHASE2
• A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency — COMPLETED · PHASE3
• A Study of GS3-007a for Oral Suspension in the Diagnosis of Adult Growth Hormone Deficiency (AGHD) — TERMINATED · PHASE2
• Post-Marketing Surveillance (Special Use-results Surveillance on Long-term Use) With Sogroya® — ACTIVE_NOT_RECRUITING
• BELux Children OutcoME During A(@)Dulthood With GHD — NOT_YET_RECRUITING · NA
• Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients — COMPLETED · PHASE4
• The Effects of Growth Hormone Treatment Discontinuation in Adults on Metabolic Profile, Body Composition and Quality Of Life (GAMBOL Study) — OTHER
• Open-label Extension Study to Evaluate the Safety of Long-term Twice-monthly Administration of Somavaratan in Adult Growth Hormone Deficiency (AGHD) — TERMINATED · PHASE2
• A Phase 3, Multicenter Study To Evaluate The Efficacy And Safety Of MOD-4023 In Adults With Growth Hormone Deficiency — TERMINATED · PHASE3
• Versartis International Trial in Adults With Long-Acting Growth Hormone — COMPLETED · PHASE2
• A Trial Investigating the Safety, Tolerability, Availability and Distribution in the Body of Once-weekly Long-acting Growth Hormone (Somapacitan) Compared to Once Daily Norditropin NordiFlex® in Adults With Growth Hormone Deficiency — COMPLETED · PHASE1
• First Human Dose Trial of NNC0195-0092 (Somapacitan) in Healthy Subjects — COMPLETED · PHASE1
• Trial to Compare the Efficacy and Safety of NNC0195-0092 (Somapacitan) With Placebo and Norditropin® FlexPro® (Somatropin) in Adults With Growth Hormone Deficiency. — COMPLETED · PHASE3
• A Trial to Evaluate the Safety of Once Weekly Dosing of Somapacitan (NNC0195-0092) and Daily Norditropin® FlexPro® for 52 Weeks in Previously Human Growth Hormone Treated Japanese Adults With Growth Hormone Deficiency — COMPLETED · PHASE3
• A Trial to Compare the Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone Deficiency — COMPLETED · PHASE3
• Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Various Degrees of Impaired Renal Function Compared to Subjects With Normal Renal Function — COMPLETED · PHASE1
• French National Registry of Adults With Growth Hormone Deficiency Treated With Somatropin — COMPLETED
• MOD-4023 (Long-Lasting Human Growth Hormone (hGH)) Study in Growth Hormone Deficient Adults (GHDA) — COMPLETED · PHASE2
• Investigation of Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Multiple Doses of Somapacitan in Subjects With Mild and Moderate Degrees of Hepatic Impairment Compared to Subjects With Normal Hepatic Function. — COMPLETED · PHASE1
• An Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Adult Growth Hormone Deficiency (AGHD) — COMPLETED · PHASE4
• Observational Prospective Study on Patients Treated With Norditropin® — COMPLETED
• A Clinical Study in AGHD to Assess Safety, Tolerability and Efficacy of GX-H9 — COMPLETED · PHASE2
• The Glucagon Stimulation Test for Evaluation of Adult Growth Hormone Deficiency and Adrenocorticotropic Axis — COMPLETED · NA
• A Non-inferiority Phase 2 Study to Evaluate the Safety and Efficacy of PEG-rhGH in the Treatment of AGHD — OTHER · PHASE2
• Long-term Trial on Growth Hormone Deficiency in Adults (GHDA) — COMPLETED · PHASE3
• Growth Hormone Deficiency in Adults (GHDA) — COMPLETED · PHASE3
• Cardiovascular Effects on Growth Hormone Therapy in Adults With Growth Hormone Deficiency — TERMINATED · PHASE4
• A Single Dose Trial in Healthy Caucasians and Japanese Subjects Investigating the Pharmacokinetics of Somatropin — COMPLETED · PHASE1
• Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 — COMPLETED · PHASE2
• Effect of Growth Hormone on Bone Mineral Density in Young Adults With Child-hood Onset Growth Hormone Deficiency — COMPLETED · PHASE3
• Assessing the Minimal Important Difference (MID) of the Treatment Related Impact Measure-Adult Growth Hormone Deficiency (TRIM-AGHD) — COMPLETED
• Long-term Trial on Growth Hormone Deficiency in Adults (GHDA) — COMPLETED · PHASE3
• Safety and Efficacy Study of Recombinant Human Growth Hormone in Adult Growth Hormone Deficiency Patients — COMPLETED · PHASE2
• An Observational Study Validating a Score That Quantifies the Therapeutic Response to Treatment With Norditropin® — COMPLETED
• Safety and Efficacy of Long-term Somatropin Treatment in Adults — COMPLETED
• Observational Study of the Safety and Efficacy of Norditropin® in Adult Patients With Growth Hormone Deficiency — COMPLETED
• Metabolic Endocrinology and Growth Hormone in Adults — COMPLETED
• Treatment of Adults With Growth Hormone Deficiency — COMPLETED · PHASE3
• Treatment of Adults With Growth Hormone Deficiency — COMPLETED · PHASE3
• Extension Study on Safety of Long-Term Growth Hormone Replacement in Adult Patients With Growth Hormone Deficiency — COMPLETED · PHASE3
• Study of an Extended-Release, Crystalline Formulation of Recombinant Human Growth Hormone (ALTU-238) in Growth Hormone Deficient Adults to Determine Pharmacokinetics, Pharmacodynamics, and Drug Safety — COMPLETED · PHASE2

Refine this search